AMFI Registered Mutual Fund Distributor | SEBI registered Investment Adviser
FSM LOGO

                    


titl_l_gif
Factsheets
title_r_gif
Share
Print

RELIANCE PHARMA FUND- GROWTH


INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies

Fund Category Equity
Fund Class Pharmaceuticals
Fund Type Open-Ended
Options Growth
FUND INFO
Launch Date April 3, 2006
Launch Price Rs. 10.00
Latest NAV Price (Click here for price history) Rs. 143.78 (August 30, 2016)
Fundsupermart Risk Rating 10-Highest Risk

Minimum Initial Investment Rs. 5,000 / -
Minimum Subsequent Investment Rs. 1,000 / -
Minimum Redemption Amount Rs. 100
Minimum Holding Period -
Transaction Time for Redemption 1:50 PM
Entry Load NIL
Exit Load 1% if redeemed or switched out on or before completion of 1 year from the date of allottment of units. NIL if redeemed or switched out after the completion of 1 year from the date of allottment of units.
FUND PERFORMANCE (ANNUALIZED RETURNS)
Period 1 wk 1 mth 3 mth 6 mth 1 yr 3 yr 5 yr since inception
NAV Returns (%) - INR 1.04 0.3 7.1 7.7 -3.8 26.4 21.7 20.4
Performance figures (as of August 29, 2016)

The performance figures in the table above are calculated using NAV prices, assuming growth option. Performance figures of over 1 year are annualised.(Eg. A 33.1% gain in 3 years works out to a 10% gain per year when annualised.)

Click here to see how the fund has performed against other funds or an index.

OTHER PERFORMANCE DATA
Calendar Year 2015 2014 2013 2012 2011
RELIANCE PHARMA FUND- GROWTH (%) 19.37 49.46 20.87 34.84 -11.02

The performance figures in the table above are calculated using NAV, assuming Growth option. Performance figures of over 1 year are annualised.(Eg. A 33.1% gain in 3 years works out to a 10% gain per year when annualised.)

3 yr Annualised Volatility 16.67
3 yr Sharpe ratio 1.14
The above figures (as of August 30, 2016)


Please note:

  1. Unit price is the NAV price, sales charges are not included.
  2. Investment involves risk. The price of securities may go down as well as up, and under certain circumstances an investor may sustain a total or substantial loss of investment. Past performance is not necessarily indicative of the future or likely performance of the fund. Investors should read the relevant fund's prospectus for details before making any investment decision. An Investor should make an appraisal of the risks involved in investing in these products and should consult their own independent and professional advisors, to ensure that any decision made is suitable with regards to their circumstances and financial position.
  3. This fact sheet is compiled by fundsupermart.com from the individual fund management company's public information material, and meant for information only. Whilst all attempts have been made by fundsupermart.com to present the information accurately and completely, mistakes and omissions do sometimes occur. Readers are advised to read the Offer Document/SID/SAI before making any investment decision. It is important that you read our disclaimers.
  4. Fund's performance refers to the performance of the growth option of this scheme.